Live at IDWeek 2015

Ian Crozier, MD, has been described as the sickest person ever to survive Ebola Virus Disease, or EVD. Presenting his story as a survivor at IDWeek 2015, he said he was “happy to be here.”

Treatment with dolutegravir as part of an optimized background regimen demonstrated good virologic efficacy in adolescents infected with HIV, researchers at IDWeek 2015 reported.

Researchers reported a “low to moderate” influenza vaccine effectiveness for preventing influenza admissions during the northern hemisphere’s 2013/2014 flu season.

Among Medicare beneficiaries diagnosed with acute myocardial infarction (AMI), filling a prescription for an antimicrobial was positively associated with an adverse cardiac event within the week, a study presented at IDWeek 2015 has found.

The combination of vancomycin plus piperacillin/tazobactam resulted in a significantly higher incidence of acute kidney injury than when vancomycin was combined with cefepime, a study reported at IDWeek 2015.

A single infusion of the human monoclonal antibody bezlotoxumab (BEZ), with or without actoxumab (ACT), improves prevention of recurrent C. difficile infection (rCDI), according to a presentation at IDWeek 2015 of data combined from the double-blind, randomized Phase 3 MODIFY I and MODIFY II studies.